Fabp7 gene encodes a brain-specific fatty acid-binding protein that is widely used as a marker for neural stem cells. Here, we report that the activity of rat Fabp7 promoter was regulated directly by a transcription factor, Pax6. Deletion analyses identified an essential region (−837 to −64 from transcription start site) in the rat Fabp7 promoter.
| INTRODUCTION
Fatty acid-binding protein 7 (Fabp7, also known as brain fatty acid-binding protein, B-FABP, and brain lipid-binding protein, BLBP) is a small intracellular member of the Fabp protein family (Matsumata, Inada, & Osumi, 2016; Smathers & Petersen, 2011) . The Fabp7 gene is expressed both in the developing brain and in the adult brain, and it appears to contribute to the intracellular transport of free fatty acids to various organelles, including the nucleus, mitochondria, peroxisomes and lysosomes (Owada, 2008) . In rodents, defects in the Fabp7 gene have been linked to the reduced neural stem cell maintenance and impaired neural plasticity (Arai et al., 2005; Matsumata et al., 2012; Owada et al., 2006) . Moreover, in humans, polymorphisms in the FABP7 gene have been reported in a variety of mental disorders, including schizophrenia and autism (Maekawa et al., 2010; Shimamoto et al., 2014) . Thus, understanding the mechanisms that regulate Fabp7 expression in brain development is highly relevant.
Fabp7 has been identified as a signaling factor that regulates neuronal and glial differentiation (Feng, Hatten, & Heintz, 1994) . Moreover, Fabp7 expression is strongly induced in glial cells when cocultured with differentiating neurons (Feng & Heintz, 1995) . A previous study reported that POU transcription factor is required for Fabp7 expression in mouse embryos (Josephson et al., 1998) . A deletion series in the Fabp7 promoter region in transgenic mice revealed three regulatory elements, one of which contains a putativebinding site for CSL Su(H) , Lag-1]-type) transcription factors in the Notch signaling pathway (Anthony, Mason, Gridley, Fishell, & Heintz, 2005; Feng & Heintz, 1995) .
We previously reported that expression of the rat Fabp7 gene is regulated by Pax6, a transcription factor that plays a critical role in brain development (Arai et al., 2005; Numayama-Tsuruta et al., 2010) . DNA microarray analyses revealed that Fabp7 expression is reduced significantly in the Pax6 spontaneous mutant rat (rSey 2 ).
Pax6 over-expression by electroporation into cultured rat embryos leads to ectopic Fabp7 expression (Arai et al., 2005) , suggesting that Fabp7 expression is downstream of Pax6. In addition, Pax6 and Fabp7 are co-expressed in human malignant glioma cell lines, and both deletion analyses and gel mobility shift assays of the Fabp7 promoter region revealed that Pax6 can bind to the Fabp7 promoter (Liu, Monckton, & Godbout, 2012) . In mice, by contrast, Fabp7 expression was independent on the Pax6 (Arai et al., 2005) . Therefore, the molecular mechanisms that control Fabp7 gene expression have remained to be examined in detail.
Here, we showed that activity of the rat Fabp7 promoter is regulated by a transcription factor Pax6. A series of deletions in the rat Fabp7 promoter region revealed that Pax6 is required for regulating Fabp7 promoter activity in rat embryos and in the embryonic mouse brain cell line MEB5. ChIP-qPCR analysis showed that Pax6 bound to the Fabp7 promoter region directly. The rat Fabp7 promoter activity did not seem to require other possible regulatory sequences of Pbx/POU and CBF1 that have been reported to be essential for Fabp7 expression in mice. These results suggest that expression of the rat Fabp7 gene is regulated mainly by Pax6 during the rat brain development. Different Fabp7 expression between rat and mouse embryos could be explained by different requirement of transcription factors, Pax6 and POU/CBF1, respectively.
| RESULTS
We previously reported that Fabp7 expression is significantly reduced in embryonic rSey 2 /rSey 2 rats and is induced by the ectopic expression of a Pax6 construct introduced by electroporation in cultured whole embryos (Arai et al., 2005) .
To identify the regions in the Fabp7 promoter that are essential for regulation by Pax6, we introduced reporter genes under the control of the Fabp7 promoter into cultured rat embryos. The 7-kb upstream region of the rat Fabp7 gene contains at least five distinct sequences that are similar to the putative Pax6 PD-binding motif ( Figure 1a) . A comparison of the genomic sequences in the rat, mouse and human Fabp7 promoter regions suggests that the region located −5.5 kb of the Fabp7 gene is a likely candidate for the regulatory region, given their sequence similarity. To identify the specific regulatory regions, we generated plasmids that contain the EGFP cDNA fused to various lengths of the Fabp7 promoter region (pFabp7-EGFPs) and introduced these constructs into the developing nervous tissue of cultured rat embryos by electroporation (Figure 1b) . Successful region for electroporation was monitored by activity of the constitutive active DsRed2 plasmid. EGFP was expressed in the embryos that received the reporter genes containing the −5.7 kb region of the Fabp7 promoter, and EGFP expression was still observed when the promoter region was shortened to −1.8 kb (Figure 1c ). EGFP expression was still driven by the −1.2 kb and −0.8 kb Fabp7 promoter regions (with slightly reduced expression) in the wild-type embryos, but not in rSey 2 /rSey 2 embryos, suggesting that expression requires Pax6 ( Figure 1d ). Introducing the plasmid with −1.2 kb Fabp7 promoter into wild-type embryo resulted in clear EGFP expression in the hindbrain but faint EGFP expression in the forebrain (Figure 1d , panel −1,190+/+). Fabp7 expression in the forebrain is relatively week at this stage (E11.5) of the rat embryo (Arai et al., 2005) , possibly resulting in the faint EGFP expression caused by low activity of Fabp7 promoter. EGFP expression was abolished in both the wild-type and rSey 2 /rSey 2 embryos upon deletion of the upstream 173-bp sequence ( Figure 1d ). We then confirmed the Fabp7 promoter region that is required for transcription via Pax6 using a luciferase reporter gene (Luc2) fused to the promoter using a cultured MEB5 cells, which express endogenous Pax6 (see Figure 2a) . First, Luc activity driven by the rat Fabp7 promoter was confirmed in MEB5 cells transfected with the −5,713 expression plasmid (Figure 2c ). Deleting the upstream region (containing the putative Pax6 PD-binding motif) had no significant effect on promoter activity compared with the −5,713 construct (Figure 2c, vector) . These results are consistent with the EGFP reporter activity in cultured embryos that the −837-bp Fabp7 promoter region is sufficient for induction by Pax6. Over-expressing Pax6 had no significant effect on Luc activity in either the −5,713 bp or the −837 bp reporter plasmid. However, expressing a dominant-negative Pax6 mutant significantly reduced promoter activity, suggesting that Pax6 binding drives activity of the rat Fabp7 promoter (Figure 2b and c). Furthermore, to identify the region related with regulation of rat Fabp7 promoter activity by Pax6, an intensive deletion analysis of the promoter region was performed using MEB5 cells. A series of deletions in the promoter region (from position −5,713 to −837) had no significant effect on Fabp7 promoter activity ( Figure 3a) ; in contrast, further deletions in the Fabp7 promoter (from position −731 to −413) significantly reduced promoter activity, suggesting the presence of enhancer elements (Figure 3b ). However, additional deletions (from position −731 to −413) caused a progressive reduction in promoter activity (Figure 3c ). At last, selectively deleting the region from position −413 to −63 greatly reduced promoter activity, even though the upstream sequence (i.e., from position −731 to −413) was intact ( Figure 3c ). These results suggest that the sequence from position −413 to −64 contributes to coordinated transcription of the Fabp7 gene.
To assess the possibility that Pax6 directly regulates the expression of Fabp7 gene, we examined enrichment of Pax6 at the promoter regions of Fabp7 in rat astrocyte primary culture cells by ChIP-qPCR (Figure 4) . The result showed enrichments of Pax6 at the promoter regions of Fabp7 (position F I G U R E 1 The promoter/enhancer region of the rat Fabp7 gene. (a) Homology of the −7 kb/+3-kb genome sequences between the mouse, rat and human Fabp7 promoter. Homology plots were generated using the program VISTA (Mayor et al., 2000) . The red arrows indicate PD (paired domain of Pax6)-binding site-like sequences identified using TFBIND (Tsunoda & Takagi, 1999) and MatInspector (Genomatix). The exons in the Fabp7 gene are indicated as open boxes. (b) DNA constructs used for the EGFP reporter assay. The indicated lengths of rat Fabp7 promoter/ enhancer sequences were fused to an EGFP reporter gene. These reporter constructs were cotransfected by electroporation into the rat embryonic brain together with DsRed2 and Pax6 cDNA driven by the CMV-IE enhancer and the chicken β-actin promoter. (c) Reporter gene expression in electroporated brains of wild-type rat embryos. Fabp7 promoter/enhancer activity is shown as EGFP expression (green) and was co-expressed in DsRed2-expressing cells (magenta). between −900 and −654) and Slc1a2 (as a positive control; position from −8,017 to −7,854 relative to start codon of first exon), while such enrichments of Pax6 were not observed at the transcription starting sites (TSSs) of Cryaa and of Dppa3 (positions from −157 to −94 and from −111 to −20 relative to start codon of first exon, respectively) as negative control loci ( Figure 4b ). As the Fabp7 promoter region contains a putative Pax6-binding motif predicted by JASPAR2018 database (Figure 4a ), the region then was divided into three regions (upstream, middle and downstream) and the enrichment of each region was analyzed by ChIP-qPCR to specify the Pax6-binding sequence (Figure 4c ). However, we detected the enrichment with all three regions, and there was no significant difference between the control (Full) and each region ( Figure 4c ). Therefore, we concluded to assume that the promoter region may contain a few Pax6-binding sites, although Pax6 specifically binds the rat Fabp7 promoter and directly regulates the expression of Fabp7. The region from position −837 to −654 in the rat Fabp7 promoter does not contain a clear consensus sequence for Pax6 PD binding, although a potential Pax box has been reported in the mouse Fabp7 promoter (Feng & Heintz, 1995) suggest that the CBF1/RBP-J motif-but not the Pbx/POU motif-showed the tendency of reduced activity of the Fabp7 promoter even though there was no significant difference between the control and deletion construct ( Figure 5c ). Over-expression of Pax6, however, increased the activity of promoter lacking CBF1-binding site significantly (Figure 5c ), suggesting that major contribution of Pax6 to the rat Fabp7 promoter activity.
Because the specific mutagenesis of CBF1-binding motif resulted in tendency of reduction in Fabp7 promoter activity, binding of CBF1 to the Fabp7 promoter was evaluated by performing a gel mobility shift assay ( Figure 6 ). A fluorescently labeled DNA fragment containing the CBF1/RBP-J motif showed a clear binding signal when incubated with nuclear extracts obtained from MEB5 cells, RGC-6 cells (a rat brain glial tumor cell line) and embryonic rat cerebral cortex ( Figure 6 ). Specific binding of CBF1 to the motif in the Fabp7 promoter was also confirmed by a competition assay using unlabeled fragments and by a super shift of the signal in the presence of the anti-CBF1 antibody ( Figure 6 ). Specific binding of CBF1 to the Fabp7 promoter was found in nuclear extracts obtained from both heterozygous rSey 2 /+ embryos and homozygous rSey 2 /rSey 2 embryos (Figure 6c ), in which Fabp7 expression was significantly reduced and eliminated, respectively. Considering the previous reports and the results shown in this study, rat Fabp7 expression is 
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-5.7 -4.6 -3.3 -2.5-1.9 kb -5.7 -4.6 -3.3 -2.5-1.9 kb -5.7 -4.6 -3.3 -2.5-1.9 kb ** ** ** ** ** ** * ** ** ** ** ** ** ** ** * dependent on Pax6 but not Pbx/POU and CBF1, while mouse Fabp7 expression has a reverse dependency (Anthony et al., 2005; Josephson et al., 1998) . These results suggest the less contribution of CBF1 to driving Fabp7 expression in rat embryos that lack Pax6.
At last, we examined whether the Fabp7 promoter activity is induced by canonical Pax6 and/or the Pax6 isoform Pax6(5a) (Epstein, Cai, Glaser, Jepeal, & Maas, 1994) . We co-electroporated pFabp7-EGFPs with various Pax6 expression constructs (Figure 7a ). Our previous study showed that strong Pax6 expression was observed in the telencephalon, diencephalon and hindbrain in E12.5 rat embryo (Figure 7b ; Arai et al., 2005) . First, we confirmed that over-expressing Pax6 increased the expression of EGFP driven by the −3.1 kb (−3,094) and −1.2 kb (−1,190 (Figure 7c ). In the absence of exogenous Pax6, promoter activity of both Fabp7 promoters was observed in the wild-type and heterozygous embryos but not in the homozygous embryo (Figure 7c ), suggesting that the −1.2-kbp Fabp7 promoter region may be sufficient for induction by Pax6. The enhanced expression was observed in rSey 2 /+ embryos that were electroporated with pFabp7-EGFP (−3,094) and canonical Pax6, but not in embryos that were electroporated with Pax6(5a) or with an alternative form that lacks the paired domain (Pax6ΔPD) (Figure 7d ). This result suggests that canonical Pax6 is required for the rat Fabp7 promoter activity in the rat embryo.
| DISCUSSION
Here, we report that the promoter of the rat Fabp7 gene is regulated directly by the transcription factor Pax6. Our results suggest that Pax6 binds directly in the primary cultured astrocytes and drives the Fabp7 promoter in rat embryos and MEB5 cells. We also showed that CBF1 contribution to the Fabp7 promoter activity was limited, even though CBF1 binding to the promoter region was observed by the gel mobility shift assay using nuclear extracts isolated from MEB5 cells, RGC-6 cells and embryonic rat cerebral cortex.
| Direct regulation of Fabp7 expression by Pax6
In this study, a series of deletion analyses and a subsequent ChIP-qPCR analysis for the rat Fabp7 promoter region revealed specific regulation of Fabp7 expression by direct binding of Pax6. It has previously been reported that Fabp7 expression is regulated by Pax6 in human glioma cell lines, tumors and tumor neurospheres (Liu et al., 2012) . Their promoter deletion analysis revealed that the Pax6-binding site is located within the region between position −1,033 bp and −862 bp from the transcription start site in the Fabp7 gene. Moreover, their gel mobility shift assay revealed that Pax6 binds directly to the Fabp7 promoter. In addition, DNA footprint experiments suggest that Pax6 binds to the human Fabp7 promoter; however, a clear binding region could not be identified due to the weak signal. Our results demonstrate that Fabp7 expression is (Figure 7 ), suggesting major contribution of the canonical Pax6 to the regulation of rat Fabp7 gene. The regulation of Fabp7 expression by Pax6 is also supported by over-expression of a dominant-negative mutant (Pax6-EnR), resulting in significant decrease in the promoter activity (Figure 2b and c) . The ChIPqPCR analysis also showed the direct and specific Pax6 binding to the Fabp7 promoter region (Figure 4) . However, clear specific binding element could not be identified by a series of promoter deletion analyses ( Figure 3) and ChIP-qPCR analysis ( Figure 5 ). Indeed, an above-mentioned study using human glioma samples has concluded that Pax6 may bind to two separate DNA elements (Liu et al., 2012) ; thus, multiple Pax6-binding sites may also be present in the rat Fabp7 promoter.
| Less contribution of Pbx/POU and CBF1 consensus sequences to the rat Fabp7 promoter activity
Previous studies using mouse embryos found that POU and CBF1 transcription factors are required for Fabp7 expression (Anthony et al., 2005; Josephson et al., 1998) . A POU-binding motif located from −370 to −362 contributed to the mouse Fabp7 promoter activity and to actual POU binding in mouse embryos (Josephson et al., 1998) . DNA sequence upstream to the mouse Fabp7 gene contains a consensus CBF1-binding motif (located from −265 to −230 relative to the transcription start site; TSS), and deleting this motif significantly reduced the activity of the Fabp7 promoter fused to a LacZ reporter gene in transgenic mouse embryos (Anthony et al., 2005; Josephson et al., 1998) . In our results, on the other hand, the rat Fabp7 promoter also contains consensus Pbx/POU and CBF1-binding motifs, and their deletions caused no significant reduction in the promoter activity in MEB5 cells (Figure 5c ). However, the results of our gel mobility shift assay showed that CBF1 binds directly to the consensus sequence in the rat Fabp7 promoter (Figure 6 ), consistent with the previous finding that CBF1 drives Fabp7 expression in mice (Anthony et al., 2005) . These results suggest that both Pbx/POU and CBF1 have less critical roles on the regulation of Fabp7 expression in rats. Genes to Cells INADA et Al.
| Pax6-dependent regulation of the rat

Fabp7 promoter activity
Our ChIP-qPCR, site-specific deletion, and Pax6 overexpression analyses revealed that the Fabp7 promoter can be regulated directly and mainly by Pax6 in the embryonic rat brain. In an interesting manner, we found that over-expressing Pax6 can overcome the reduced activity in the rat Fabp7 promoter in which the CBF1-binding site is deleted (Figure 5c ), suggesting that Pax6 and CBF1 might regulate the Fabp7 promoter via a coordinated mechanism. In contrast, in the mouse brain, CBF1 seems to be sufficient to drive Fabp7 expression (Anthony et al., 2005) ; this finding may explain the intriguing species difference in which Fabp7 expression is unaffected in homozygous Pax6 mutant (Sey/Sey) mice (Arai et al., 2005) . On the other hand, over-expressing Pax6 does not induce Fabp7 expression in Fabp7-negative human glioma cell lines (Liu et al., 2012) , suggesting that Pax6 may not be sufficient to drive Fabp7 expression in these cell lines. These results are consistent with our own results in which Pax6 is necessary for inducing the rat Fabp7 promoter activity both in rat embryos and in the murine cell line MEB5. The different Pax6 dependency on Fabp7 expression among mouse, rat and human might further be explained by homology of Fabp7 promoter sequence. As shown in Figure 1a , the promoter region upstream −837 bp shows no homology between rat versus human and human versus mouse. The difference might reflect an evolutional tract of regulation of Fabp7 expression, such as Pax6-independent regulation in mouse, Pax6-dependent regulation in rat and synergistic regulation by Pax6 and cofactors in human. In summary, our results provide compelling evidence that the rat Fabp7 promoter is mainly regulated with the transcription factor Pax6. The regulation of Fabp7 expression in rats and mice is Pax6-dependent and Pax6-independent, respectively. The regulation of Fabp7 expression may explain the discrepancy in Fabp7 expression between the rat and mouse brain during development; Fabp7 is expressed robustly in the rat cortical primordium at the midembryonic stage, but not in mice at the same developmental stage (Arai et al., 2005) . This difference in Fabp7 expression between species may be interesting from the perspective of the brain's evolution. Fabp7 is expressed specifically in radial glia or neuroepithelial cells (i.e., neural progenitor cells), which have long, thin processes that reach from the ventricle to the surface of the primordial brain (Anthony et al., 2005; Kurtz et al., 1994) . We previously reported that knocking down Fabp7 expression leads to morphological changes in F I G U R E 6 Gel mobility shift assay for confirming CBF1 binding. A gel mobility shift assay was performed using nuclear extracts obtained from MEB5 cells (a), RGC-6 cells (b) and cerebral cortex isolated from E14.5 rat embryos (c). An unlabeled oligonucleotide probe matching the CBF1-binding sequence (CBF1) or its mutant (CBF1mut1) was used for competitive binding experiments. Antibodies against CBF1 (αCBF1) and Pax6 (αPax6) were used for the super-shift experiments. The arrows and triangles indicate the CBF1/DNA probe complex and the CBF1/DNA probe/αCBF1 complex, respectively. NE, nuclear extract neuroepithelial cells, resulting in the lack of both apical and basal processes, in the developing rat embryo (Arai et al., 2005) . Thus, the regulation of Fabp7 expression by Pax6 might contribute to making longer radial processes within the primordial brain, thereby facilitating the formation of a proportionally larger brain in rats compared with mice. consists of two DNA-binding motifs, "PAI" and "RED". Exon 5a, which is encoded in the Pax6(5a) protein via alternative splicing, is indicated. The Pax6ΔPD isoform lacks the PD domain and arises from the use of an alternative promoter and an alternative translation start codon located in exon 7 (Kammandel et al., 1999; Kim & Lauderdale, 2006) . In the rSey 2 mutant rat, the Pax6 gene contains a 1-bp insertion near the PD-coding sequence; the resulting frame-shifted protein is not detectable using the Pax6 antibody (Numayama-Tsuruta, Arai, & Osumi, 2007; Osumi et al., 1997) . (b) Expression pattern of the Pax6 transcript in rat embryo at E12.5. The photograph was adapted from the report by (Arai et al., 2005) . but not in brains that were cotransfected with Pax6(5a), Pax6ΔPD or an empty vector. The three Pax6 isoforms were detected using whole-mount immunohistochemistry with a polyclonal antibody against 17 residues in the C-terminus of the Pax6 protein (Inoue et al., 2000) . Scale bar: 1 mm (Osumi et al., 1997) , which were maintained at Tohoku University School of Medicine. Wild-type Sprague-Dawley (SD) rats were purchased from Charles River Japan. Midday on the day in which the vaginal plug was observed was designated as embryonic day 0.5 (E0.5). All experimental procedures were approved by the Committee for Animal Experimentation at Tohoku University (2008MdA-67, 2013MdA-438, 2016MdA-142, 2017MdA-221) .
| Plasmid DNA
Plasmids for reporter constructs were generated using standard cloning methods. DNA fragments containing the rat Fabp7 promoter/enhancer region (spanning from −7-kb upstream of the transcription start site to the 3′ region of exon 1) were amplified by PCR and cloned into the pGEM-T Easy vector (Promega). The Sph I/Nco I fragment was subcloned into the Luc2 reporter vector pGL4.10 (Promega). The resulting pGL4Fabp7-5.7k construct was digested using the restriction enzymes listed below, blunt-ended using T4 DNA polymerase and self-ligated to create a deletion series of Luc2 reporter constructs. The following sites were digested using the correspond- The EGFP reporter construct pFabp7-5.7kEGFP was generated by replacing the luciferase cDNA in pGL4Fabp7-5.7k with EGFP cDNA from the pEGFP-1 vector (Clontech); this construct was used to generate the above-mentioned deletion series.
The rat Fapb7-Luc2 reporter plasmid pGAL4Fabp7-0.8k (−837) was used as a template for site-directed mutagenesis using the QuikChange II Site-Directed Mutagenesis Kit (Stratagene/Agilent Technologies) and the following primer pairs: Pbx-POU-MG-F/R (5′-GCAGCGAAAG GAAGTgAATC TGAATGCCCT ATTATC-3′ and 5′-GATAATAGGG CATTCAGATT cACTTCCTTT CGCTGC-3′), Pbx-POU-MG2-F/R (5′-CAGCAGCGAA AGGAAGTCgA cCTGAATGCC CTATTATCC-3′ and 5′-GGATAATAGG GCATTCAGgT cGACTTCCTT TCGCTGCTG-3′), and CBF1-MG1-F/R (5′-TCTCTGTCTT CGGTgCaCAG GCCCCGCTGA CTTCCTATGG AGCA-3′ and 5′-TGCTCCATAG GAAGTCAGCG GGGCCTGtGc ACCGAAGACA GAGA-3′); these primer pairs were designed to obtain mutated binding sites for Pbx, Pbx/POU and CBF1, respectively. All products were confirmed by DNA sequencing. A pCAX expression vector containing the chick β-actin promoter and the cytomegalovirus immediate early (CMV-IE) enhancer was used for the over-expression experiments. We used the pCAX-DsRed2 construct (generated by Dr T. Nomura) to detect the electroporated areas in the embryonic brains.
The construct pCAX-mPax6 was used as a canonical Pax6 expression plasmid (Takahashi & Osumi, 2002) . To express Pax6 with the additional exon 5a (pCAX-Pax6(5a)), a 255-bp Pst I/Nhe I fragment of pCAX-mPax6 was replaced with a 297-bp cDNA fragment containing exon 5a, which was amplified from cDNA obtained from rat embryonic hindbrain as described previously (Numayama-Tsuruta et al., 2010) . The pCAX-Pax6ΔPD has a deleted 315-bp EcoR I fragment and is translated from an alternative ATG in exon 4. The pCAXPax6-EnR construct was kindly provided by Dr M. Kengaku (Kyoto University) (Yamasaki et al., 2001 ).
| Electroporation of cultured rat embryos
Cultured rat embryos were electroporated as described previously (Takahashi, Makino, Kikkawa, & Osumi, 2014; Takahashi & Osumi, 2002) . The plasmid vectors (pCAX-DsRed2, pCAXPax6 and pFabp7-EGFPs) were prepared at a concentration of 5 mg/ml and microinjected into the rhombencephalic, mesencephalic and telencephalic vesicles at E11.5. Square pulses (70 V, 5 Hz) were delivered into the embryos using an electroporator (CUY21, Neppa Gene, Tokyo, Japan). Whole embryo culture was performed for 24 hr after electroporation.
| Culture of cell lines
The murine neural stem cell line MEB5 (Nakagaito et al., 1998) was maintained as floating neurospheres in Dulbecco's modified Eagle medium (DMEM) containing 5 μg/ml insulin, 10 ng/ml EGF, 50 μg/ml transferrin, 10 ng/ml biotin and 30 nM sodium selenite. For the immunostaining experiments and Luc assays, the MEB5 cells were mechanically dissociated by trituration to form a single-cell suspension; the cells were then seeded on poly-L-lysine (PLL), fibronectin and laminin-coated glass-bottom dishes or 12-well plates. The rat glial cell line RGC-6 was maintained in DMEM containing 10% fetal bovine serum (FBS) (Benda, Lightbody, Sato, Levine, & Sweet, 1968) .
| Preparation of tissues and nuclear extracts
Nuclear extracts were prepared from either embryonic cerebral cortex or cultured cells using the method of Dignam,
|
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INADA et Al. Lebovitz, and Roeder (1983) , with slight modifications. At E14.5, five pairs of dorsal telencephalon (cerebral hemisphere) were dissected from wild-type, rSey 2 /+ and rSey 2 / rSey 2 rat embryos. The dissected tissues were rinsed twice in ice-cold PBS and homogenized by cutting into small pieces followed by trituration. Dissociated cells were pelleted by centrifugation and resuspended (in 100 μl/individual genotype of embryos or 400 μl/cultured cells) in low-salt buffer A containing 10 mM HEPES-NaOH (pH 7.9), 1.5 mM MgCl 2 , 10 mM KCl, 1 mM dithiothreitol (DTT) and 1× protease inhibitor cocktail (Complete Mini, Roche); the samples were incubated on ice for 15 min. After adding 1/16th volume of 10% NP-40 and vortexing, the nuclear pellets were collected by centrifugation. Nuclear proteins were extracted by mixing with 12.5 μl (for each embryonic cortex sample) or 50 μl (for cultured cells) of high-salt buffer C containing 20 mM HEPES-NaOH (pH 7.9), 1.5 mM MgCl 2 , 400 mM NaCl, 25% glycerol, 1 mM DTT and 1× protease inhibitor cocktail; the samples were incubated on ice for 15 min. The nuclear extracts were cleared by centrifugation, divided into small aliquots and stored at −80°C. Supernatants (1 μl each) were used for the binding reactions in the gel mobility shift assays. MEB5 neurospheres and RGC-6 cells were cultured for three days to reach 100% confluence. Nuclear extracts were prepared as described above, except the volumes of buffers A and C were 400 μl and 50 μl/two 100-mm culture dishes.
| Luciferase reporter assay
Adherent MEB5 cells were cultured overnight on coated 12-well plates. Four hours after changing the culture medium, the cells were transfected with reporter, effector and internal control vectors using FuGENE6 (Roche) in accordance with the manufacturer's protocol. The total amount of DNA was kept constant at 250 ng/well by adding an empty pBSK vector. The cells were cotransfected with 100 ng of pGL4_Fabp7-5.7k or an equimolar ratio of each deletion construct of the pGL4-based firefly luciferase 2 (Luc2) reporter together with 100 ng of pCAX effector expression plasmid and 50 ng of pGL4.74 HSV-TK promoter-driven Renilla luciferase (Rluc) vector (Promega); the Rluc vector was used as an internal control for transfection efficiency. Approximately 38 hr after transfection, the cells were rinsed twice in PBS and then lysed with 250 μl of Passive Lysis Buffer (Promega). The activities of Luc2 and Rluc in 5-20 μl of lysate were measured using the Dual-Luciferase Reporter Assay System kit (Promega) and a Lumat luminometer (Berthold Technologies) in accordance with the respective manufacturers' instructions. The ratio of Luc2/Rluc activity was used to calculate relative luciferase activity, which was normalized to the value obtained from the pGL4.10 promoter-less construct. All experiments were performed at least three times.
| Gel mobility shift assay
For the gel shift assays, 1 μl of nuclear extract, competitor DNA and antibody were mixed and preincubated at room temperature in 10 mM HEPES-NaOH (pH 7.9), 3 mM MgCl2, 6 mM DTT, 0.1 mg/ml poly[d(I-C)] and 0.5% Tween-20 for 30 min. The samples were then incubated for 30 min at room temperature with 50 fmol of IRDye700-labeled oligonucleotide probes (5′-TCTGTCTTCG GTTCCCAGGC CCCGCTGACT-3′ and 5′-AGTCAGCGGG GCCTGGGAAC CGAAGACAGA-3′) for the putative CBF1-binding site in the rat Fabp7 promoter. The total volume of each binding reaction was 10 μl. The reaction mixture contained approximately 40 mM NaCl and 2.5% glycerol derived from buffer C used for nuclear extraction. For the competition experiments, the reactions contained 2.5 pmol (50-fold excess) or 10 pmol (200-fold excess) unlabeled CBF1 probe or the mutant sequence with 2-base-pair substitutions in the putative CBF1-binding site (CBF1mut1; 5′-TCTGTCTTCG GTgCaCAGGC CCCGCTGACT-3′ and 5′-AGTCAGCGGG GCCTGtGcAC CGAAGACAGA-3′). The anti-CBF1 (anti-RBP-Jκ, Cosmo Bio) and anti-Pax6 antibodies were added for the super-shift assay. The reaction mixtures were separated by electrophoresis in a 4% nondenaturing polyacrylamide gel, and infrared fluorescence of the probe was measured using an infrared imaging system (Odyssey, LI-COR Biosciences).
| Immunostaining
Whole-mount immunostaining of Pax6, Pax6(5a) and Pax6ΔPD over-expressed in rSey 2 /rSey 2 embryonic brains was performed as described previously (Numayama-Tsuruta et al., 2010) , except the primary antibody was a polyclonal antibody against the C-terminal region of Pax6 (Inoue, Nakamura, & Osumi, 2000) . For immunofluorescence staining, dissociated MEB5 cells were plated on coated 35-mm glass-bottom dishes (IWAKI). Three days after plating, the cells were fixed with 4% paraformaldehyde and subjected to immunostaining; the nuclei were counterstained with DAPI. The antibody against Fabp7 was a generous gift from Dr Y. Owada (Tohoku University). The monoclonal anti-rat Ki-67 antibody (clone MIB-5) and Alexa Fluor-conjugated secondary antibodies (anti-rabbit IgG/Alexa 488 and anti-mouse IgG/Alexa 546) were purchased from Dako and Molecular Probes, respectively. The fluorescence signals were detected using an inverted fluorescence microscope (IX71, Olympus) equipped with U-MWU/U-MNIBA3/U-MWIG3 filter sets and a color CCD camera (DP70, Olympus).
| Primary cultured rat astrocytes
Cell cultures of rat cortical astrocytes were prepared essentially as described previously (Sakurai & Osumi, 2008) . In brief, cerebral cortices were isolated from postnatal Day 2 SD rat. After meninges were removed carefully, the tissues were gently dissociated by trituration with a pipette. Cells were pelleted at 1,000×g for 2 min, resuspended in DMEM supplemented with 10% FBS and then plated in a PLL-coated 75 cm 2 culture (T75) flask. The medium was changed every 3 days until the culture reached confluence, and then, the astrocytes culture was purified by shaking for 12-15 hr to remove microglia and oligodendrocytes as much as possible (McCarthy & de Vellis, 1980) . Then remained astrocytes were collected by trypsinization with Trypsin-EDTA and used for ChIP-qPCR analysis.
| ChIP-qPCR analysis
ChIP assays were performed as previously described with minor modifications (Mochizuki, Tachibana, Saitou, Tokitake, & Matsui, 2012) . In brief, about 1 × 10 7 cells of rat astrocyte primary culture were cross-linked by adding 16% formaldehyde (Thermo) to the cell suspension to a final concentration of 1% and were incubated at 37°C with gentle inverting for 10 min. The chromatin was fragmented by sonication (Diagenode Bioruptor 2; 30 s ON with 30 s OFF; total processing time of 20 min; output level high). Anti-PAX6 antibody (Millipore, AB2237) and isotype control IgG (Millipore, 12-370) were used for the assays. For each immunoprecipitation, 25 μl of Dynabeads Protein G and A (Invitrogen) was incubated with 10 μg of the indicated antibody in 500 μl RIPA-150 mM NaCl for 4 to 8 hr at 4°C with rotation and washed twice with 500 μl of icecold RIPA-150 mM NaCl. An aliquot of the fragmented chromatin (500 μl) was incubated with the antibody-bound Dynabeads overnight at 4°C with rotation. The enrichment of specific regions in each of the immunoprecipitated DNA was analyzed by quantitative PCR using the Power SYBR Green PCR Master Mix (Applied Biosystems). PCR signals were detected by CFX Connect (BioRad). The sequences of the PCR primers are listed below. The data were obtained from two independent experiments. 
